Global Covid-19 Impact on Telemedicine Technologies and Services Market
Global Covid-19 Impact on Telemedicine Technologies and Services Market

Covid-19 Impact on Telemedicine Technologies and Services Comprehensive Study by Application (Dermatology, Gynecology, Neurology, Cardiology, Orthopedics, Others), Solutions (Hardware (Telemedicine Kits and Monitors), Software (Integrated and Standalone), Services (Tele-Consultation, Tele-Monitoring, Tele-Care, Real-Time Analysis & Interaction, Others)), End-User (Hospitals, Clinics, Diagnostic Centers, Others) Players and Region - Global Market Outlook to 2026

Covid-19 Impact on Telemedicine Technologies and Services Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 224 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Covid-19 Impact on Telemedicine Technologies and Services Market Scope
Telemedicine is the practice of using communications technology to link healthcare providers to their patients and each other over great distances. It refers specifically to remote clinical services. Telemedicine offers a means to help transform healthcare itself by encouraging greater consumer involvement in decision making and providing new approaches to maintaining healthy lifestyle services when participants are at different locations. In 2020, the Telemedicine adoption rate has significantly improved owing to the novel coronavirus globally. There was a drastic shift from 11 percent to 76 percent when it came to people who want to use telehealth. North America is the largest telemedicine market globally. Government initiatives and grants to increase the adoption of telemedicine solutions are expected to boost the market in the United Kingdom.

The Covid-19 Impact on Telemedicine Technologies and Services market study is segmented, by Application (Dermatology, Gynecology, Neurology, Cardiology, Orthopedics and Others) and major geographies with country level break-up.

The United Kingdom telemedicine technologies and services market is highly focused on the number of key market players. The players are adopting advanced techniques for the development of products and services to expand their portfolio, geographical reach, increase customer base, and garner market share. Constant upgrade and innovation in products of telemedicine technologies is the key strategy adopted by major players in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Covid-19 Impact on Telemedicine Technologies and Services market throughout the predicted period.

OBS Medical Ltd. (United Kingdom), Immedicare (United Kingdom), Babylon Health (United Kingdom), NHS (United Kingdom), Push Doctor (United Kingdom), Involve Visual Collaboration Limited (United Kingdom), Tele Medicine Clinic (United Kingdom), GE Healthcare (United States), AMD Global Telemedicine, Inc. (United States) and Honeywell International, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Abbott (United States), Telemedicine, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Aerotel Medical Systems Ltd. (Israel), F. Hoffmann-La Roche Ltd (Switzerland), GlobalMedia Group LLC (United States), LifeWatch AG (Switzerland), McKesson Corporation (United States), Cardiocom, LLC, (United States) and Medtronic plc (Ireland).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Covid-19 Impact on Telemedicine Technologies and Services market by Type, Application and Region.

On the basis of geography, the market of Covid-19 Impact on Telemedicine Technologies and Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In June 2016, the National Health Service of the United Kingdom announced that it was offering remote monitoring medical devices and apps to help millions of people manage chronic conditions. and In February 2017, Abbott MRI Pacemaker received the United States FDA approval for its novel advanced product MRI Pacemaker for both the Assurity MRI pacemaker and Tendril MRI pacing lead.


Market Trend
  • Modern technology such as HIPAA Compliant Video-Conferencing Tools
  • Adoption of mHealth, and Artificial Intelligence as a Standard of Care

Market Drivers
  • Increase in Incidence of Chronic Diseases and Adoption of Telemedicine Solutions
  • Rise in Demand for Self-Care Devices/Solutions Such As mHealth and Remote Monitoring
  • Increased Traditional Health Care Costs, and Increase in Digital Health Users
  • Development in Healthcare Infrastructure and Rise in Telemedicine Products

Opportunities
  • Growing Technological Developments in Telemedicine and Healthcare such as Adoption of 5G
  • Internet of Medical Things, Blockchain, and Cloud Technology
  • Increasing Research & Development Activities to Develop New, Innovative, and Technologically Advanced Products

Restraints
  • Highly Cost-Intensive and Requires Huge Installation Costs
  • Privacy and Security Concerns about Patient Information

Challenges
  • Stringent Regulatory Framework
  • Lack of Skilled Workforce or Resources


Key Target Audience
Telemedicine Technologies and Services Providers, System and Software Developers, Laboratories & Research Institutes, Hospitals & Clinics, End-Use Industries and Others

Frequently asked questions:
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Covid-19 Impact on Telemedicine Technologies and Services Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Application
  • Dermatology
  • Gynecology
  • Neurology
  • Cardiology
  • Orthopedics
  • Others
By Solutions
  • Hardware (Telemedicine Kits and Monitors)
  • Software (Integrated and Standalone)
  • Services (Tele-Consultation, Tele-Monitoring, Tele-Care, Real-Time Analysis & Interaction, Others)

By End-User
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Incidence of Chronic Diseases and Adoption of Telemedicine Solutions
      • 3.2.2. Rise in Demand for Self-Care Devices/Solutions Such As mHealth and Remote Monitoring
      • 3.2.3. Increased Traditional Health Care Costs, and Increase in Digital Health Users
      • 3.2.4. Development in Healthcare Infrastructure and Rise in Telemedicine Products
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Framework
      • 3.3.2. Lack of Skilled Workforce or Resources
    • 3.4. Market Trends
      • 3.4.1. Modern technology such as HIPAA Compliant Video-Conferencing Tools
      • 3.4.2. Adoption of mHealth, and Artificial Intelligence as a Standard of Care
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Covid-19 Impact on Telemedicine Technologies and Services, by Application, Solutions, End-User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Covid-19 Impact on Telemedicine Technologies and Services (Value)
      • 5.2.1. Global Covid-19 Impact on Telemedicine Technologies and Services by: Application (Value)
        • 5.2.1.1. Dermatology
        • 5.2.1.2. Gynecology
        • 5.2.1.3. Neurology
        • 5.2.1.4. Cardiology
        • 5.2.1.5. Orthopedics
        • 5.2.1.6. Others
      • 5.2.2. Global Covid-19 Impact on Telemedicine Technologies and Services by: Solutions (Value)
        • 5.2.2.1. Hardware (Telemedicine Kits and Monitors)
        • 5.2.2.2. Software (Integrated and Standalone)
        • 5.2.2.3. Services (Tele-Consultation, Tele-Monitoring, Tele-Care, Real-Time Analysis & Interaction, Others)
      • 5.2.3. Global Covid-19 Impact on Telemedicine Technologies and Services by: End-User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Diagnostic Centers
        • 5.2.3.4. Others
      • 5.2.4. Global Covid-19 Impact on Telemedicine Technologies and Services Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Covid-19 Impact on Telemedicine Technologies and Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. OBS Medical Ltd. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Immedicare (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Babylon Health (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. NHS (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Push Doctor (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Involve Visual Collaboration Limited (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Tele Medicine Clinic (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GE Healthcare (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AMD Global Telemedicine, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Honeywell International, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Covid-19 Impact on Telemedicine Technologies and Services Sale, by Application, Solutions, End-User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Covid-19 Impact on Telemedicine Technologies and Services (Value)
      • 7.2.1. Global Covid-19 Impact on Telemedicine Technologies and Services by: Application (Value)
        • 7.2.1.1. Dermatology
        • 7.2.1.2. Gynecology
        • 7.2.1.3. Neurology
        • 7.2.1.4. Cardiology
        • 7.2.1.5. Orthopedics
        • 7.2.1.6. Others
      • 7.2.2. Global Covid-19 Impact on Telemedicine Technologies and Services by: Solutions (Value)
        • 7.2.2.1. Hardware (Telemedicine Kits and Monitors)
        • 7.2.2.2. Software (Integrated and Standalone)
        • 7.2.2.3. Services (Tele-Consultation, Tele-Monitoring, Tele-Care, Real-Time Analysis & Interaction, Others)
      • 7.2.3. Global Covid-19 Impact on Telemedicine Technologies and Services by: End-User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Diagnostic Centers
        • 7.2.3.4. Others
      • 7.2.4. Global Covid-19 Impact on Telemedicine Technologies and Services Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Covid-19 Impact on Telemedicine Technologies and Services: by Application(USD Million)
  • Table 2. Covid-19 Impact on Telemedicine Technologies and Services Dermatology , by Region USD Million (2015-2020)
  • Table 3. Covid-19 Impact on Telemedicine Technologies and Services Gynecology , by Region USD Million (2015-2020)
  • Table 4. Covid-19 Impact on Telemedicine Technologies and Services Neurology , by Region USD Million (2015-2020)
  • Table 5. Covid-19 Impact on Telemedicine Technologies and Services Cardiology , by Region USD Million (2015-2020)
  • Table 6. Covid-19 Impact on Telemedicine Technologies and Services Orthopedics , by Region USD Million (2015-2020)
  • Table 7. Covid-19 Impact on Telemedicine Technologies and Services Others , by Region USD Million (2015-2020)
  • Table 8. Covid-19 Impact on Telemedicine Technologies and Services: by Solutions(USD Million)
  • Table 9. Covid-19 Impact on Telemedicine Technologies and Services Hardware (Telemedicine Kits and Monitors) , by Region USD Million (2015-2020)
  • Table 10. Covid-19 Impact on Telemedicine Technologies and Services Software (Integrated and Standalone) , by Region USD Million (2015-2020)
  • Table 11. Covid-19 Impact on Telemedicine Technologies and Services Services (Tele-Consultation, Tele-Monitoring, Tele-Care, Real-Time Analysis & Interaction, Others) , by Region USD Million (2015-2020)
  • Table 12. Covid-19 Impact on Telemedicine Technologies and Services: by End-User(USD Million)
  • Table 13. Covid-19 Impact on Telemedicine Technologies and Services Hospitals , by Region USD Million (2015-2020)
  • Table 14. Covid-19 Impact on Telemedicine Technologies and Services Clinics , by Region USD Million (2015-2020)
  • Table 15. Covid-19 Impact on Telemedicine Technologies and Services Diagnostic Centers , by Region USD Million (2015-2020)
  • Table 16. Covid-19 Impact on Telemedicine Technologies and Services Others , by Region USD Million (2015-2020)
  • Table 17. South America Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2015-2020)
  • Table 18. South America Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 19. South America Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 20. South America Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 21. Brazil Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 22. Brazil Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 23. Brazil Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 24. Argentina Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 25. Argentina Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 26. Argentina Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 27. Rest of South America Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 28. Rest of South America Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 29. Rest of South America Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 30. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 32. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 33. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 34. China Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 35. China Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 36. China Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 37. Japan Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 38. Japan Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 39. Japan Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 40. India Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 41. India Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 42. India Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 43. South Korea Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 44. South Korea Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 45. South Korea Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 46. Taiwan Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 47. Taiwan Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 48. Taiwan Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 49. Australia Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 50. Australia Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 51. Australia Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 55. Europe Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2015-2020)
  • Table 56. Europe Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 57. Europe Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 58. Europe Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 59. Germany Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 60. Germany Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 61. Germany Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 62. France Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 63. France Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 64. France Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 65. Italy Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 66. Italy Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 67. Italy Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 68. United Kingdom Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 69. United Kingdom Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 70. United Kingdom Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 71. Netherlands Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 72. Netherlands Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 73. Netherlands Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 74. Rest of Europe Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 75. Rest of Europe Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 76. Rest of Europe Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 77. MEA Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2015-2020)
  • Table 78. MEA Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 79. MEA Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 80. MEA Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 81. Middle East Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 82. Middle East Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 83. Middle East Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 84. Africa Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 85. Africa Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 86. Africa Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 87. North America Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2015-2020)
  • Table 88. North America Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 89. North America Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 90. North America Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 91. United States Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 92. United States Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 93. United States Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 94. Canada Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 95. Canada Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 96. Canada Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 97. Mexico Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2015-2020)
  • Table 98. Mexico Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2015-2020)
  • Table 99. Mexico Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2015-2020)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Covid-19 Impact on Telemedicine Technologies and Services: by Application(USD Million)
  • Table 111. Covid-19 Impact on Telemedicine Technologies and Services Dermatology , by Region USD Million (2021-2026)
  • Table 112. Covid-19 Impact on Telemedicine Technologies and Services Gynecology , by Region USD Million (2021-2026)
  • Table 113. Covid-19 Impact on Telemedicine Technologies and Services Neurology , by Region USD Million (2021-2026)
  • Table 114. Covid-19 Impact on Telemedicine Technologies and Services Cardiology , by Region USD Million (2021-2026)
  • Table 115. Covid-19 Impact on Telemedicine Technologies and Services Orthopedics , by Region USD Million (2021-2026)
  • Table 116. Covid-19 Impact on Telemedicine Technologies and Services Others , by Region USD Million (2021-2026)
  • Table 117. Covid-19 Impact on Telemedicine Technologies and Services: by Solutions(USD Million)
  • Table 118. Covid-19 Impact on Telemedicine Technologies and Services Hardware (Telemedicine Kits and Monitors) , by Region USD Million (2021-2026)
  • Table 119. Covid-19 Impact on Telemedicine Technologies and Services Software (Integrated and Standalone) , by Region USD Million (2021-2026)
  • Table 120. Covid-19 Impact on Telemedicine Technologies and Services Services (Tele-Consultation, Tele-Monitoring, Tele-Care, Real-Time Analysis & Interaction, Others) , by Region USD Million (2021-2026)
  • Table 121. Covid-19 Impact on Telemedicine Technologies and Services: by End-User(USD Million)
  • Table 122. Covid-19 Impact on Telemedicine Technologies and Services Hospitals , by Region USD Million (2021-2026)
  • Table 123. Covid-19 Impact on Telemedicine Technologies and Services Clinics , by Region USD Million (2021-2026)
  • Table 124. Covid-19 Impact on Telemedicine Technologies and Services Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 125. Covid-19 Impact on Telemedicine Technologies and Services Others , by Region USD Million (2021-2026)
  • Table 126. South America Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2021-2026)
  • Table 127. South America Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 128. South America Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 129. South America Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 130. Brazil Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 131. Brazil Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 132. Brazil Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 133. Argentina Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 134. Argentina Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 135. Argentina Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 136. Rest of South America Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 137. Rest of South America Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 138. Rest of South America Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 139. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2021-2026)
  • Table 140. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 141. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 142. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 143. China Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 144. China Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 145. China Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 146. Japan Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 147. Japan Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 148. Japan Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 149. India Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 150. India Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 151. India Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 152. South Korea Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 153. South Korea Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 154. South Korea Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 155. Taiwan Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 156. Taiwan Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 157. Taiwan Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 158. Australia Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 159. Australia Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 160. Australia Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 161. Rest of Asia-Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 162. Rest of Asia-Pacific Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 164. Europe Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2021-2026)
  • Table 165. Europe Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 166. Europe Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 167. Europe Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 168. Germany Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 169. Germany Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 170. Germany Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 171. France Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 172. France Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 173. France Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 174. Italy Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 175. Italy Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 176. Italy Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 177. United Kingdom Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 178. United Kingdom Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 179. United Kingdom Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 180. Netherlands Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 181. Netherlands Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 182. Netherlands Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 183. Rest of Europe Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 184. Rest of Europe Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 185. Rest of Europe Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 186. MEA Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2021-2026)
  • Table 187. MEA Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 188. MEA Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 189. MEA Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 190. Middle East Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 191. Middle East Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 192. Middle East Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 193. Africa Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 194. Africa Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 195. Africa Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 196. North America Covid-19 Impact on Telemedicine Technologies and Services, by Country USD Million (2021-2026)
  • Table 197. North America Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 198. North America Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 199. North America Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 200. United States Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 201. United States Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 202. United States Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 203. Canada Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 204. Canada Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 205. Canada Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 206. Mexico Covid-19 Impact on Telemedicine Technologies and Services, by Application USD Million (2021-2026)
  • Table 207. Mexico Covid-19 Impact on Telemedicine Technologies and Services, by Solutions USD Million (2021-2026)
  • Table 208. Mexico Covid-19 Impact on Telemedicine Technologies and Services, by End-User USD Million (2021-2026)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Covid-19 Impact on Telemedicine Technologies and Services: by Application USD Million (2015-2020)
  • Figure 5. Global Covid-19 Impact on Telemedicine Technologies and Services: by Solutions USD Million (2015-2020)
  • Figure 6. Global Covid-19 Impact on Telemedicine Technologies and Services: by End-User USD Million (2015-2020)
  • Figure 7. South America Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 8. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 9. Europe Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 10. MEA Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 11. North America Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 12. Global Covid-19 Impact on Telemedicine Technologies and Services share by Players 2020 (%)
  • Figure 13. Global Covid-19 Impact on Telemedicine Technologies and Services share by Players (Top 3) 2020(%)
  • Figure 14. Global Covid-19 Impact on Telemedicine Technologies and Services share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. OBS Medical Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. OBS Medical Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 18. Immedicare (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. Immedicare (United Kingdom) Revenue: by Geography 2020
  • Figure 20. Babylon Health (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. Babylon Health (United Kingdom) Revenue: by Geography 2020
  • Figure 22. NHS (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. NHS (United Kingdom) Revenue: by Geography 2020
  • Figure 24. Push Doctor (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Push Doctor (United Kingdom) Revenue: by Geography 2020
  • Figure 26. Involve Visual Collaboration Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Involve Visual Collaboration Limited (United Kingdom) Revenue: by Geography 2020
  • Figure 28. Tele Medicine Clinic (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Tele Medicine Clinic (United Kingdom) Revenue: by Geography 2020
  • Figure 30. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 31. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 32. AMD Global Telemedicine, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. AMD Global Telemedicine, Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Honeywell International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Honeywell International, Inc. (United States) Revenue: by Geography 2020
  • Figure 36. Global Covid-19 Impact on Telemedicine Technologies and Services: by Application USD Million (2021-2026)
  • Figure 37. Global Covid-19 Impact on Telemedicine Technologies and Services: by Solutions USD Million (2021-2026)
  • Figure 38. Global Covid-19 Impact on Telemedicine Technologies and Services: by End-User USD Million (2021-2026)
  • Figure 39. South America Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 40. Asia Pacific Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 41. Europe Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 42. MEA Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
  • Figure 43. North America Covid-19 Impact on Telemedicine Technologies and Services Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • OBS Medical Ltd. (United Kingdom)
  • Immedicare (United Kingdom)
  • Babylon Health (United Kingdom)
  • NHS (United Kingdom)
  • Push Doctor (United Kingdom)
  • Involve Visual Collaboration Limited (United Kingdom)
  • Tele Medicine Clinic (United Kingdom)
  • GE Healthcare (United States)
  • AMD Global Telemedicine, Inc. (United States)
  • Honeywell International, Inc. (United States)
Additional players considered in the study are as follows:
Abbott (United States) , Telemedicine, Inc. (United States) , Koninklijke Philips N.V. (Netherlands) , Aerotel Medical Systems Ltd. (Israel) , F. Hoffmann-La Roche Ltd (Switzerland) , GlobalMedia Group LLC (United States) , LifeWatch AG (Switzerland) , McKesson Corporation (United States) , Cardiocom, LLC, (United States) , Medtronic plc (Ireland)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation